Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 123.55
  • 0.18  0.15%
    Today's Change
  • 123.37
    Previous Close
  • Today
    52 Week Low - High
2:16 pm ET 3/23/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding778 million
Market Cap$96 billion
Return on Equity ttm31.94%
Last DividendCELG:US does not pay a dividend
EPS: Year Actual ttm4.010
EPS: Year Est. 12/17 ttm7.226
EPS: Quarterly Actual 12/16 1.61
EPS: Quarterly Est. 3/17 1.64
Price/Earnings ttm30.81
Relative Price/Earnings1.431
Earnings Growth Rate27.23
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$11 billion
Net Income$2 billion
Total Assets$28 billion
Web Sitewww.celgene.com

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!